Multigene panel testing for hereditary breast and ovarian cancers: An analysis of 1303 BRCA-negative Chinese patients. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This ...
Prescribing preferences for hormone sensitive (HR+) metastatic breast cancer (mBC) in the CDK 4/6 inhibitor (CDK 4/6i) era. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This ...
Novo Nordisk ((NVO)) announced an update on their ongoing clinical study.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced ...
Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is currently conducting a study titled ‘Real-World ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback